BIOLARGO, INC. (55)
Browse by Contract Category
Contracts
-
Purchase Agreement, dated as of December 13, 2022, by and between BioLargo, Inc. and Lincoln Park Capital Fund, LLC
(Filed With SEC on December 19, 2022)
-
Form of Indemnity Agreement
(Filed With SEC on November 3, 2022)
-
Amendment dated June 30, 2020 to Consulting Agreement dated December 30, 2015 between Clyra Medical and Beach House Consulting LLC
(Filed With SEC on July 7, 2020)
-
Amendment dated June 30, 2020 to License Agreement with Clyra Medical Technologies, Inc
(Filed With SEC on July 7, 2020)
-
Registration Rights Agreement, dated as of December 13, 2022, by and between BioLargo, Inc. and Lincoln Park Capital Fund, LLC
(Filed With SEC on December 19, 2022)
-
Form of Board Member Agreement
(Filed With SEC on November 3, 2022)
-
Engagement Extension Agreement dated as of March 22, 2022 between BioLargo, Inc. and Charles K. Dargan, II
(Filed With SEC on March 24, 2022)
-
Agreement dated March 3, 2022, by and between Clyra Medical Technologies, Inc., and BioLargo, Inc
(Filed With SEC on March 8, 2022)
-
Agreement dated March 1, 2022, by and between Scion Solutions, LLC, Clyra Medical Technologies, Inc., and BioLargo, Inc
(Filed With SEC on March 8, 2022)
-
Third Amendment dated August 10, 2020 to Promissory Note issued to Vernal Bay Investments, LLC on September 19, 2018
(Filed With SEC on May 19, 2021)
-
Amended and restated note issued to Chappy Bean on August 12, 2019
(Filed With SEC on May 19, 2021)
-
Second Amendment dated August 12, 2019, to Promissory Note issued to Chappy Bean, LLC dated September 19, 2018
(Filed With SEC on May 19, 2021)
-
Third Amendment dated August 10, 2020, to Promissory Note issued to Chappy Bean, LLC dated September 19, 2018
(Filed With SEC on May 19, 2021)
-
Final Payoff Agreement dated May 18, 2021 to Promissory Note issued to Chappy Bean, LLC dated September 19, 2018
(Filed With SEC on May 19, 2021)
-
Final Payoff Agreement dated May 17, 2021 to Promissory Note issued to Vernal Bay Investments, LLC on September 19, 2018
(Filed With SEC on May 19, 2021)
-
Warrant issued to $50,000 Convertible Noteholder on March 1, 2020
(Filed With SEC on March 30, 2021)
-
Amendment to $50,000 Convertible Note dated March 8, 2018
(Filed With SEC on March 30, 2021)
-
Engagement Extension Agreement dated as of March 18, 2021 between BioLargo, Inc. and Charles K. Dargan, II
(Filed With SEC on March 19, 2021)
-
Warrant issued in 2020 Unit Offering
(Filed With SEC on August 14, 2020)
-
Revolving Line of Credit Note issued by Clyra Medical to Vernal Bay on June 30, 2020
(Filed With SEC on July 7, 2020)
-
Revolving Line of Credit Agreement dated June 30, 2020, between Clyra Medical and Vernal Bay
(Filed With SEC on July 7, 2020)
-
Security Agreement dated June 30, 2020, between Clyra Medical and Vernal Bay
(Filed With SEC on July 7, 2020)
-
Purchase Agreement, dated as of March 30, 2020 by and between BioLargo, Inc. and Lincoln Park Capital Fund, LLC
(Filed With SEC on March 31, 2020)
-
Registration Rights Agreement, dated as of March 30, 2020, by and between BioLargo, Inc. and Lincoln Park Capital Fund, LLC
(Filed With SEC on March 31, 2020)
-
Engagement Extension Agreement dated as of February 23, 2020 between BioLargo, Inc. and Charles K. Dargan, II
(Filed With SEC on February 27, 2020)
-
Warrant issued March 2018, expiring March 2023
(Filed With SEC on September 17, 2019)
-
Form of warrant issued January 2019 to Lincoln Park, expiring January 2024
(Filed With SEC on September 17, 2019)
-
Form of warrant issued January 2019 to Lincoln Park, expiring January 2024
(Filed With SEC on August 29, 2019)
-
Warrant issued March 2018, expiring March 2023
(Filed With SEC on August 29, 2019)
-
Warrant issued to Vernal August 12, 2019
(Filed With SEC on August 14, 2019)
-
Amended and restated note issued to Vernal August 12, 2019
(Filed With SEC on August 14, 2019)
-
Amendment dated August 12, 2019 to Promissory Note issued to Vernal Bay Investments, LLC on September 19, 2018
(Filed With SEC on August 14, 2019)
-
Warrant to purchase 1.2 million shares issued August 9, 2019 to $600,000 note holder
(Filed With SEC on August 14, 2019)
-
$600,000 Promissory note dated August 9, 2019
(Filed With SEC on August 14, 2019)
-
Stock purchase warrant issued to OID twelve-month investors
(Filed With SEC on August 2, 2019)
-
OID twelve-month promissory note
(Filed With SEC on August 2, 2019)
-
Lock-Up Agreement dated May 28, 2019
(Filed With SEC on June 24, 2019)
-
Provenzano Employment Agreement dated May 28, 2019
(Filed With SEC on June 24, 2019)
-
Securities Purchase Agreement by and between BioLargo, Inc., and EMA Financial, LP dated June 4, 2019
(Filed With SEC on June 7, 2019)
-
Amendment #1 to the Convertible Note issued on June 4, 2019 to EMA Capital, LP
(Filed With SEC on June 7, 2019)
-
10% Convertible Promissory Note issued to EMA Financial, LP dated June 4, 2019
(Filed With SEC on June 7, 2019)
-
Convertible Promissory Note issued to Crossover Capital dated May 10, 2019
(Filed With SEC on May 15, 2019)
-
Securities Purchase Agreement by and between BioLargo, Inc., and Crossover Capital dated May 10, 2019
(Filed With SEC on May 15, 2019)
-
10% Convertible Promissory Note issued to Bellridge Capital, LP dated April 18, 2019
(Filed With SEC on April 23, 2019)
-
Securities Purchase Agreement by and between BioLargo, Inc., and Bellridge Capital, LP dated April 18, 2019
(Filed With SEC on April 23, 2019)
-
Amendment dated March 5, 2019 to Convertible Promissory Note issued to Tangiers Global, LLC dated January 31, 2019
(Filed With SEC on March 8, 2019)
-
Amendment dated March 5, 2019 to Promissory Note issued to Chappy Bean, LLC on September 19, 2018
(Filed With SEC on March 8, 2019)
-
Amendment dated March 5, 2019 to Promissory Note issued to Vernal Bay Investments, LLC on September 19, 2018
(Filed With SEC on March 8, 2019)
-
Stock Purchase Warrant issued to Lincoln Park Capital on January 31, 2019
(Filed With SEC on February 11, 2019)
-
Convertible Promissory Note issued to Tangiers Global, LLC dated January 31, 2019
(Filed With SEC on February 11, 2019)
-
Engagement Extension Agreement dated as of January 16, 2019 between BioLargo, Inc. and Charles K. Dargan, II
(Filed With SEC on January 18, 2019)
-
Convertible Promissory Note issued to Vista Capital Investments LLC dated January 7, 2019
(Filed With SEC on January 11, 2019)
-
January 2019 Amendment to Promissory Note dated December 14, 2017, by and between BioLargo, Inc. and Vista Capital Investments, LLC
(Filed With SEC on January 11, 2019)
-
Engagement Extension Agreement dated as of December 31, 2017 between BioLargo, Inc. and Charles K. Dargan, II
(Filed With SEC on January 3, 2018)
-
Option to purchase common stock issued to Charles K. Dargan dated December 31, 2017
(Filed With SEC on January 3, 2018)